EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPD

Xiaobing Wang, Xiaoxi Xu, Chunlei Cheng, Jing Zheng, Wenkun Liu, Yuwen Xu, Jihang Xu, Lihua Wu, Xianhai Sun, Weijian Wang, Hao Fang

Pharmaceutical Science Advances · 2026-12 · 4 · 100136

DOI: 10.1016/j.pscia.2026.100136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Science Advances, 2026-12. Verfasst von Xiaobing Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Institute for Food and Drug Control, Jinan, Shandong, 250101, China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taishan Industry Leading Talents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Chronic obstructive pulmonary disease (COPD)Dry powder inhalerFormulation developmentIndacaterol maleateTiotropium bromide

Autor:innen und Institutionen

  • Shandong Institute for Food and Drug Control, Jinan, Shandong, 250101, China.
  • School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
  • Industrial Technology Foundation Public Service Platform, Jinan, Shandong, 250101, China.
  • College of Chemistry, Beijing Normal University, Beijing, 100875, China.
  • Jewim Pharmaceutical (Shandong) Company Limited, Taian, Shandong, 271000, China.

Förderung

  • Taishan Industry Leading Talents

Zitieren

APA

Wang, X., Xu, X., Cheng, C., Zheng, J., Liu, W., Xu, Y., Xu, J., Wu, L., Sun, X., Wang, W., & Fang, H. (2026). Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPD. Pharmaceutical Science Advances, 4, 100136. https://doi.org/10.1016/j.pscia.2026.100136

Vancouver

Wang X, Xu X, Cheng C, Zheng J, Liu W, Xu Y, et al. Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPD. Pharmaceutical Science Advances. 2026;4:100136. doi:10.1016/j.pscia.2026.100136

BibTeX
@article{Wang2026,
  author = {Wang, Xiaobing and Xu, Xiaoxi and Cheng, Chunlei and Zheng, Jing and Liu, Wenkun and Xu, Yuwen and Xu, Jihang and Wu, Lihua and Sun, Xianhai and Wang, Weijian and Fang, Hao},
  title = {Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPD},
  journal = {Pharmaceutical Science Advances},
  year = {2026},
  volume = {4},
  pages = {100136},
  doi = {10.1016/j.pscia.2026.100136}
}
Kostenlos starten →